About Aware Recovery Care
Services
Type of Care
Substance use treatment; Detoxification
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)
Outpatient; Outpatient detoxification; Intensive outpatient treatment; Outpatient methadone/buprenorphine or naltrexone treatment
Opioid Medications used in Treatment
Buprenorphine used in Treatment; Naltrexone used in Treatment
External Opioid Medications Source
No formal relationship with prescribing entity
Type of Alcohol Use Disorder Treatment
Accepts clients using medication assisted treatment for alcohol use disorder but prescribed elsewhere; This facility administers/prescribes medication for alcohol use disorder
External Source of Medications Used for Alcohol Use Disorder Treatment
No formal relationship with prescribing entity
Type of Opioid Treatment
Buprenorphine detoxification; Buprenorphine maintenance; Prescribes buprenorphine; Prescribes naltrexone; Relapse prevention with naltrexone; Accepts clients using MAT but prescribed elsewhere; Lofexidine or Clonidine detoxification; Maintenance service with medically supervised withdrawal after stabilization
Pharmacotherapies
Acamprosate (Campral®); Disulfiram; Buprenorphine with naloxone; Naltrexone (oral); Naltrexone (extended-release, injectable); Clonidine; Medication for mental disorders; Non-nicotine smoking/tobacco cessation
Treatment Approaches
Brief intervention; Cognitive behavioral therapy; Motivational interviewing; Matrix Model; Relapse prevention; Substance use disorder counseling; Telemedicine/telehealth therapy
Facility Operation (e.g., Private, Public)
Private for-profit organization
License/Certification/Accreditation
State Substance use treatment agency; State department of health; The Joint Commission
Payment/Insurance/Funding Accepted
Private health insurance; Cash or self-payment
Assessment/Pre-treatment
Comprehensive mental health assessment; Comprehensive substance use assessment; Interim services for clients; Outreach to persons in the community; Screening for tobacco use; Screening for substance use; Screening for mental disorders
Testing
Breathalyzer or blood alcohol testing; Drug and alcohol oral fluid testing; Drug or alcohol urine screening
Transitional Services
Aftercare/continuing care; Discharge Planning; Naloxone and overdose education; Outcome follow-up after discharge
Recovery Support Services
Housing services; Assistance with obtaining social services; Recovery coach; Mentoring/peer support
Detoxification (medical withdrawal) Services
Alcohol Detoxification; Benzodiazepines Detoxification; Opioids detoxification; Medication routinely used during detoxification
Education and Counseling Services
Substance use disorder education; Individual counseling; Family counseling; Marital/couples counseling
Facility Smoking Policy
Smoking permitted in designated area
Age Groups Accepted
Children/Adolescents; Adults
Sex Accepted
Female; Male
Facility Vaping Policy
Vaping permitted in designated area
Ancillary Services
Case management service; Social skills development; Transportation assistance
Type of Care
Substance use treatment; Detoxification
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)
Outpatient; Outpatient detoxification; Intensive outpatient treatment; Outpatient methadone/buprenorphine or naltrexone treatment
Opioid Medications used in Treatment
Buprenorphine used in Treatment; Naltrexone used in Treatment
External Opioid Medications Source
No formal relationship with prescribing entity
Type of Alcohol Use Disorder Treatment
Accepts clients using medication assisted treatment for alcohol use disorder but prescribed elsewhere; This facility administers/prescribes medication for alcohol use disorder
External Source of Medications Used for Alcohol Use Disorder Treatment
No formal relationship with prescribing entity
Type of Opioid Treatment
Buprenorphine detoxification; Buprenorphine maintenance; Prescribes buprenorphine; Prescribes naltrexone; Relapse prevention with naltrexone; Accepts clients using MAT but prescribed elsewhere; Lofexidine or Clonidine detoxification; Maintenance service with medically supervised withdrawal after stabilization
Pharmacotherapies
Acamprosate (Campral®); Disulfiram; Buprenorphine with naloxone; Naltrexone (oral); Naltrexone (extended-release, injectable); Clonidine; Medication for mental disorders; Non-nicotine smoking/tobacco cessation
Treatment Approaches
Brief intervention; Cognitive behavioral therapy; Motivational interviewing; Matrix Model; Relapse prevention; Substance use disorder counseling; Telemedicine/telehealth therapy
Facility Operation (e.g., Private, Public)
Private for-profit organization
License/Certification/Accreditation
State Substance use treatment agency; State department of health; The Joint Commission
Payment/Insurance/Funding Accepted
Private health insurance; Cash or self-payment
Assessment/Pre-treatment
Comprehensive mental health assessment; Comprehensive substance use assessment; Interim services for clients; Outreach to persons in the community; Screening for tobacco use; Screening for substance use; Screening for mental disorders
Testing
Breathalyzer or blood alcohol testing; Drug and alcohol oral fluid testing; Drug or alcohol urine screening
Transitional Services
Aftercare/continuing care; Discharge Planning; Naloxone and overdose education; Outcome follow-up after discharge
Recovery Support Services
Housing services; Assistance with obtaining social services; Recovery coach; Mentoring/peer support
Detoxification (medical withdrawal) Services
Alcohol Detoxification; Benzodiazepines Detoxification; Opioids detoxification; Medication routinely used during detoxification
Education and Counseling Services
Substance use disorder education; Individual counseling; Family counseling; Marital/couples counseling
Facility Smoking Policy
Smoking permitted in designated area
Age Groups Accepted
Children/Adolescents; Adults
Sex Accepted
Female; Male
Facility Vaping Policy
Vaping permitted in designated area
Ancillary Services
Case management service; Social skills development; Transportation assistance
